ICYMI – Addressing health inequities: Biopharmaceutical companies are rising to the occasionnews2020-11-02T19:00:00+00:00November 2nd, 2020|The Catalyst|
U.S. trade policy must prioritize American biopharmaceutical innovation and patient accessnews2020-11-02T18:00:00+00:00November 2nd, 2020|The Catalyst|
